XENE

NASDAQ 已收盘

Xenon Pharmaceuticals

37.56 USD
▼-0.19-0.50%
盘后 41.50 0.00%
2026-11-19
市值
$3.67B
市盈率
—
EPS
-4.67
股息率
—
52 周区间
33.38 – 72.66
成交量
1.28M
Beta
0.08
目标价
71.56
52W 低 33.3852W 高 72.66
价格走势

公司简介

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders. Its product candidates include Azetukalner, a novel, potent Kv7 potassium channel opener which is in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. In a...

关联新闻